Scilex Holding (SCLX)
NASDAQ: SCLX
· Real-Time Price · USD
5.40
-0.10 (-1.82%)
At close: Jun 25, 2025, 3:59 PM
5.21
-3.52%
After-hours: Jun 25, 2025, 07:40 PM EDT
-1.82% (1D)
| Bid | 4.7 |
| Market Cap | 37.54M |
| Revenue (ttm) | 50.71M |
| Net Income (ttm) | -74.51M |
| EPS (ttm) | -15.27 |
| PE Ratio (ttm) | -0.35 |
| Forward PE | 1.59 |
| Analyst | Buy |
| Ask | 5.82 |
| Volume | 32,658 |
| Avg. Volume (20D) | 138,969 |
| Open | 5.39 |
| Previous Close | 5.50 |
| Day's Range | 5.29 - 5.48 |
| 52-Week Range | 3.60 - 78.05 |
| Beta | 1.14 |
About SCLX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SCLX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SCLX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Scilex Holding is scheduled to release its earnings on Aug 12, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-21.6%
Scilex Holding shares are trading lower after the ...
Unlock content with
Pro Subscription
2 months ago
+25.27%
Scilex Holding shares are trading higher. D. Boral Capital maintained a Buy rating on the stock.
1 year ago · https://www.defenseworld.net
Sorrento Therapeutics (OTCMKTS:SRNEQ) and bluebird bio (NASDAQ:BLUE) Financial ComparisonSorrento Therapeutics (OTCMKTS:SRNEQ – Get Free Report) and bluebird bio (NASDAQ:BLUE – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compar...
